Litcius/Paper detail

Effectiveness and Safety of Apixaban Versus Warfarin in Atrial Fibrillation Patients With Malignancy: A Propensity-Matched Analysis

Siddharth Agrawal, Ritu Tated, Hritvik Jain, Kriti Soni, Dhruvi K Joshi, Pragyat Futela, Maharshi Raval, Vikas Aggarwal, Abhishek Deshmukh, Saraschandra Vallabhajosyula

2026The American Journal of Cardiology10 citationsDOI

Topics & Concepts

ApixabanMedicineWarfarinAtrial fibrillationInternal medicineStroke (engine)Propensity score matchingRetrospective cohort studyCardiologyCohortMalignancyCohort studyGastrointestinal bleedingAnticoagulantRivaroxabanIntracerebral hemorrhageSurgeryMortality rateAnesthesiaAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementIntracerebral and Subarachnoid Hemorrhage Research
Effectiveness and Safety of Apixaban Versus Warfarin in Atrial Fibrillation Patients With Malignancy: A Propensity-Matched Analysis | Litcius